1.62
price up icon3.23%   0.07
 
loading
Entera Bio Ltd stock is traded at $1.62, with a volume of 24,403. It is up +3.23% in the last 24 hours and down -13.51% over the past month. Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
24,403
Relative Volume:
0.39
Market Cap:
$58.75M
Revenue:
$134.00K
Net Income/Loss:
$-9.93M
P/E Ratio:
-4.3784
EPS:
-0.37
Net Cash Flow:
$-6.72M
1W Performance:
-10.11%
1M Performance:
-13.51%
6M Performance:
-33.05%
1Y Performance:
+119.18%
1-Day Range:
Value
$1.5373
$1.62
1-Week Range:
Value
$1.5373
$1.79
52-Week Range:
Value
$0.52
$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Name
Name
Entera Bio Ltd
Name
Phone
972-2-532-7151
Name
Address
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
Employee
20
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
ENTX's Discussions on Twitter

Compare ENTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ENTX 1.62 58.75M 134.00K -9.93M -6.72M -0.37
VRTX 448.26 115.74B 10.63B -479.80M -1.35B 13.33
REGN 745.57 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.72 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.24 24.49B 3.30B -501.07M 1.03B 11.54

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-22-21 Initiated Aegis Capital Buy

Entera Bio Ltd Stock (ENTX) Latest News

pulisher
Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024
pulisher
Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms Buy Rating for Entera Bio (NASDAQ:ENTX) - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

Entera Bio Ltd. (ENTX) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Highlights Q3 2024 Financials and FDA Anticipation - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 08, 2024
pulisher
Oct 29, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Drops By 14.4% - MarketBeat

Oct 29, 2024
pulisher
Oct 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in September - MarketBeat

Oct 13, 2024
pulisher
Oct 07, 2024

Entera Bio outlook steady as H.C. Wainwright backs potential of total hip BMD in osteoporosis care - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Entera Bio (NASDAQ:ENTX) Rating Reiterated by HC Wainwright - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Oct 04, 2024
pulisher
Sep 30, 2024

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Entera Bio shares hold Buy rating on OXM study success By Investing.com - Investing.com Australia

Sep 29, 2024
pulisher
Sep 28, 2024

Entera Bio shares hold Buy rating on OXM study success - Investing.com

Sep 28, 2024
pulisher
Sep 27, 2024

Entera Bio's (ENTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health report promising obesity treatment study - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio And Opko Health Provide Update On Pk/Pd Results Of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate For Obesity And Metabolic Disorders - XM

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News

Sep 25, 2024
pulisher
Sep 20, 2024

Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? - MSN

Sep 20, 2024
pulisher
Sep 03, 2024

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? - MSN

Sep 03, 2024
pulisher
Sep 01, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Sep 01, 2024
pulisher
Aug 30, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Yahoo Finance

Aug 30, 2024
pulisher
Aug 20, 2024

Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewswire

Aug 20, 2024
pulisher
Aug 15, 2024

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy - Yahoo Finance

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. to Post Q3 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX) - MarketBeat

Aug 15, 2024
pulisher
Aug 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in July - MarketBeat

Aug 13, 2024
pulisher
Aug 12, 2024

Entera Bio (NASDAQ:ENTX) Releases Earnings Results - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

Entera Bio's (ENTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

HC Wainwright Reiterates Buy Rating for Entera Bio (NASDAQ:ENTX) - Defense World

Aug 12, 2024
pulisher
Aug 09, 2024

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewswire

Aug 09, 2024
pulisher
Aug 09, 2024

Virtu Financial LLC Invests $37,000 in Entera Bio Ltd. (NASDAQ:ENTX) - Defense World

Aug 09, 2024
pulisher
Aug 07, 2024

Entera Bio Ltd expected to post a loss of 6 cents a shareEarnings Preview - XM

Aug 07, 2024
pulisher
Aug 06, 2024

The 10 Best Biotech Stocks Under $5 To Buy For September 2024! - The Stock Dork

Aug 06, 2024
pulisher
Aug 02, 2024

Entera Bio shareholders approve executive compensation, board appointments - Investing.com

Aug 02, 2024
pulisher
Aug 01, 2024

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual MeetingKey SABRE Update Also Expected - StockTitan

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Trading Up 1.9% - MarketBeat

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Stock Price Up 1.9% - Defense World

Aug 01, 2024
pulisher
Jul 28, 2024

Entera Bio (NASDAQ:ENTX) & Vericel (NASDAQ:VCEL) Financial Survey - Defense World

Jul 28, 2024
pulisher
Jul 27, 2024

Short bowel syndrome Market Positive Outlook: Phase Bio , Orphan Technologies , Zealand Pharma - Newstrail

Jul 27, 2024
pulisher
Jul 23, 2024

3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years - Markets Insider

Jul 23, 2024

Entera Bio Ltd Stock (ENTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Entera Bio Ltd Stock (ENTX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Taitel Haya
Director
Jan 10 '24
Buy
0.77
7,615
5,864
25,615
LIEBERMAN GERALD M
Director
Dec 22 '23
Buy
0.71
23,952
17,006
226,961
Toledano Miranda Jayne
Chief Executive Officer
Dec 22 '23
Buy
0.71
23,952
17,006
110,752
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):